The European Medicines Agency (EMA) has approved Roche’s Vabysmo (faricimab) in single-dose prefilled syringe form for three ...
The integrated needle shield device on the safePICO self-fill syringe lowers the risk of needlestick ... you expel air bubbles from the sample. The cap seals the sample entirely to prevent contact ...
Equities research analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a report released on Friday. The firm set a “hold” rating on the ...
SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference 2023 will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for ...
Here are three significant recalls reported to the FDA since early December: ...
A Rogersville woman arrested in June after she was found living in a tent with a 7-month-old infant covered in bug bites and ...
BNP Paribas Financial Markets increased its position in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR – Free Report) by ...
CVS Health has struggled post-pandemic due to rising costs, regulatory scrutiny, and poor management decisions, leading to ...
After hours: December 12 at 6:08:29 PM EST Loading Chart for RVP ...
J.P. Morgan analyst David Adlington maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of €111.40.
Bernstein analyst Delphine Le Louet maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of €100.30.